22-50526142-C-T

Variant summary

Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM2PM5PP3_ModeratePP5

The ENST00000395681.6(TYMP):​c.1174G>A​(p.Gly392Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,485,144 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G392R) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

TYMP
ENST00000395681.6 missense

Scores

3
1
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:9U:1

Conservation

PhyloP100: 1.29

Publications

5 publications found
Variant links:
Genes affected
TYMP (HGNC:3148): (thymidine phosphorylase) This gene encodes an angiogenic factor which promotes angiogenesis in vivo and stimulates the in vitro growth of a variety of endothelial cells. It has a highly restricted target cell specificity acting only on endothelial cells. Mutations in this gene have been associated with mitochondrial neurogastrointestinal encephalomyopathy. Multiple alternatively spliced transcript variants have been identified. [provided by RefSeq, Apr 2012]
SCO2 (HGNC:10604): (synthesis of cytochrome C oxidase 2) Cytochrome c oxidase (COX) catalyzes the transfer of electrons from cytochrome c to molecular oxygen, which helps to maintain the proton gradient across the inner mitochondrial membrane that is necessary for aerobic ATP production. Human COX is a multimeric protein complex that requires several assembly factors; this gene encodes one of the COX assembly factors. The encoded protein is a metallochaperone that is involved in the biogenesis of cytochrome c oxidase subunit II. Mutations in this gene are associated with fatal infantile encephalocardiomyopathy and myopia 6. [provided by RefSeq, Oct 2014]
SCO2 Gene-Disease associations (from GenCC):
  • cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • myopia 6
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • autosomal recessive axonal charcot-marie-tooth disease due to copper metabolism defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr22-50526142-C-G is described in ClinVar as [Pathogenic]. Clinvar id is 16658.Status of the report is no_assertion_criteria_provided, 0 stars.
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 22-50526142-C-T is Pathogenic according to our data. Variant chr22-50526142-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 223064.We mark this variant Pathogenic, oryginal submission is: [Conflicting_classifications_of_pathogenicity].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TYMPNM_001953.5 linkc.1160-1G>A splice_acceptor_variant, intron_variant Intron 8 of 9 ENST00000252029.8 NP_001944.1 P19971-1E5KRG5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TYMPENST00000252029.8 linkc.1160-1G>A splice_acceptor_variant, intron_variant Intron 8 of 9 1 NM_001953.5 ENSP00000252029.3 P19971-1

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152138
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
82036
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000135
AC:
18
AN:
1333006
Hom.:
0
Cov.:
33
AF XY:
0.0000122
AC XY:
8
AN XY:
656768
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26844
American (AMR)
AF:
0.00
AC:
0
AN:
29370
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22808
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30674
South Asian (SAS)
AF:
0.00
AC:
0
AN:
73300
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
32842
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4664
European-Non Finnish (NFE)
AF:
0.0000170
AC:
18
AN:
1056954
Other (OTH)
AF:
0.00
AC:
0
AN:
55550
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
152138
Hom.:
0
Cov.:
34
AF XY:
0.0000404
AC XY:
3
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41446
American (AMR)
AF:
0.00
AC:
0
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
67990
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:9Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Mitochondrial DNA depletion syndrome 1 Pathogenic:5Uncertain:1
Dec 17, 2021
New York Genome Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 21, 2024
Baylor Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 14, 2016
GeneReviews
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Jul 04, 2020
Department of Pathophysiology and Transplantation, University of Milan
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 24, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 07, 2019
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2,PM3. -

Mitochondrial neurogastrointestinal encephalomyopathy Pathogenic:2
Sep 16, 2020
Natera, Inc.
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 29, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1160-1G>A (NM_001953.4) variant in TYMP has been reported in 4 homozygous and 1 compound heterozygous individuals with mitochondrial neurogastrointestinal encephalopathy disease (MNGIE) (Nishino 2000 and Kocaefe 2003). This variant ha s also been identified in 1/14978 of European chromosomes by Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org), though this frequency is lo w enough to be consistent with a recessive carrier frequency. This variant occur s in the invariant region (+/- 1,2) of the splice consensus sequence and is pred icted to cause altered splicing leading to an abnormal or absent protein. Bialle lic loss of function in the TYMP gene is associated with MNGIE. In summary, this variant meets our criteria to be classified as pathogenic for MNGIE in an autos omal recessive manner based on its biallelic occurrence in affected individuals and predicted impact on the protein. -

not provided Pathogenic:2
Nov 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change affects an acceptor splice site in intron 8 of the TYMP gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in TYMP are known to be pathogenic (PMID: 9924029, 15781193). This variant is present in population databases (no rsID available, gnomAD 0.002%). Disruption of this splice site has been observed in individuals with mitochondrial DNA depletion syndrome (PMID: 10852545, 12529715). This variant is also known as G3867C, G5314A. ClinVar contains an entry for this variant (Variation ID: 223064). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -

Oct 01, 2020
CeGaT Center for Human Genetics Tuebingen
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.60
D
BayesDel_noAF
Pathogenic
0.23
CADD
Uncertain
25
DANN
Uncertain
0.98
Eigen
Benign
0.18
Eigen_PC
Benign
0.069
FATHMM_MKL
Benign
0.72
D
M_CAP
Pathogenic
0.80
D
PhyloP100
1.3
ClinPred
1.0
D
GERP RS
3.2
PromoterAI
0.021
Neutral
Mutation Taster
=11/89
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.92
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.26
Position offset: -2
DS_AL_spliceai
0.92
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs797044455; hg19: chr22-50964571; COSMIC: COSV52689142; COSMIC: COSV52689142; API